Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
27.23
+2.16 (8.62%)
At close: Feb 6, 2026, 4:00 PM EST
27.64
+0.41 (1.51%)
After-hours: Feb 6, 2026, 7:57 PM EST
RGC Market Cap
RGC has a market cap or net worth of $13.46 billion as of February 6, 2026. Its market cap has increased by 20,762.22% in one year.
Market Cap
13.46B
Enterprise Value
13.46B
1-Year Change
20,762.22%
Ranking
Category
Stock Price
$27.23
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $13.46B, an increase of 11,111.43%. That is a compound annual growth rate of 181.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 12.40B | 19.38% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 48.04B |
| Teva Pharmaceutical Industries | 40.20B |
| United Therapeutics | 20.78B |
| Viatris | 16.54B |
| Neurocrine Biosciences | 13.75B |
| Elanco Animal Health | 12.12B |
| Dr. Reddy's Laboratories | 11.42B |
| Alkermes | 5.64B |